Drug
Ferricarboxymaltose
Ferricarboxymaltose: highest development phase Post-Market, developed by Vifor Pharma. 2 trial records tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Vifor Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| Ferricarboxymaltose NCT01288651 | Post-Market | Idiopathic Pulmonary Arterial Hypertension |
| ferricarboxymaltose NCT00978575 | Post-Market | Gastrointestinal Hemorrhage |
Latest
No recent events.
Follow Ferricarboxymaltose on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.